Comparison of baseline and low-dose dobutamine technetium-99m sestamibi scintigraphy with low-dose dobutamine echocardiography for predicting functional recovery after revascularization

American Journal of Cardiology

Volumn 86, Issue 2, 2000, Pages 153-157

  Leoncini, Mario ^a   Marcucci, Gabriella ^a   Sciagrà, Roberto ^b   Mondanelli, Dante ^a   Traini, Anna Maria ^a   Magni, Massimo ^a   Frascarelli, Fabio ^a   Mennuti, Alberto ^a   Dabizzi, Roberto P ^a  

^a MISERICORDIA E DOLCE HOSPITAL   (Italy)

^b Dept Clin Physiopathology U ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; ECHOCARDIOGRAPHY; FOLLOW UP; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HEART MUSCLE TENSION; HUMAN; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; CARDIOTONIC AGENTS; CORONARY DISEASE; DOBUTAMINE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034124483     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)00852-3     Document Type: Article

References (27)

1. Dakik H.A., Howell J.F., Lawrie G.M., Espada R., Weilbaecher D.G., He Z.-K., Mahmarian J.J., Verani M.S. Assessment of myocardial viability with 99m-Tc-sestamibi tomography before coronary bypass graft surgery. Correlation with histopathology and postoperative improvement in cardiac function. Circulation. 96:1997;2892-2898.
2. Maes A., Borgers M., Flameng W., Nuyts J.L., Van de Werf F., Ausma J.J., Sergeant P., Montelmans L.A. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up. J Am Coll Cardiol. 29:1997;62-68.
3. Cuocolo A., Pace L., Ricciardelli B., Chiarello M., Trimarco B., Salvatore M. Identification of viable myocardium in patients with chronic coronary artery disease comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile . J Nucl Med. 33:1992;505-511.
4. Soufer R., Dey H.M., Ng C.K., Zaret B.L. Comparison of sestamibi single photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability. Am J Cardiol. 75:1995;1214-1219.
5. Senior R., Raval U., Lahiri A. Technetium 99m-labeled sestamibi imaging reliably identifies retained contractile reserve in dyssinergic myocardial segments. J Nucl Cardiol. 2:1995;296-302.
6. Claeys M.J., Rademakers F.E., Vrints C.J., Krug B., Bosmans J.M., Conraads V., Bossaert L.L., Snoeck J.P., Blockx P.P. Comparative study of rest technetium-99m sestamibi SPET and low-dose dobutamine stress echocardiography for the early assessment of myocardial viability after acute myocardial infarction importance of the severity of the infarct-related stenosis . Eur J Nucl Med. 23:1996;748-755.
7. Hambye A.S., Vaerenberg M.M., Dobbeleir A.A., Van den Heuvel P.A., Franken P.R. Abnormal BMIPP uptake in chronically dysfunctional myocardial segments correlation with contractile response to low-dose dobutamine . J Nucl Med. 39:1998;1845-1850.
8. Dilsizian V., Arrighi J.A., Diodati J.G., Quyyumi A.A., Alavi K., Bacharach S.L., Marin-Neto J.A., Katsiyiannis P.T., Bonow R.O. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and 18F-fluorodeoxyglucose. Circulation. 89:1994;578-587.
9. Udelson J.E., Coleman P.S., Metherall J., Pandian N.G., Gomez A.R., Griffith J.L., Shea N.L., Oates E., Konstam M.A. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201-Tl and 99m Tc-sestamibi. Circulation. 89:1994;2552-2561.
10. Bisi G., Sciagrà R., Santoro G.M., Fazzini P.F. Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates feasibility and reliability for prediction of postrevascularization outcome of asynergic territories . J Am Coll Cardiol. 24:1994;1282-1289.
11. Sciagrà R., Bisi G., Santoro G.M., Zerauschek F., Sestini S., Pedenovi P., Pappagallo R., Fazzini P.F. Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery. J Am Coll Cardiol. 30:1997;384-391.
12. Barillà F., De Vincentis G., Mangieri E., Ciavolella M., Panittieri G., Scopinaro F., Critelli G., Campa P. Recovery of contractility of viable myocardium during inotropic stimulation is not dependent on an increase of myocardial blood flow in the absence of collateral filling. J Am Coll Cardiol. 33:1999;697-704.
13. Roelants V, Pasquet A, Robert A, D'Hondt AM, Vanoverschelde JL, Melin J. Comparison of rest and low-dose dobutamine sestamibi perfusion SPECT for delineation of reversible left ventricular ischemic dysfunction (abstr). Circulation 1996;94:I-239.
14. Mairesse G.H., Marwick T.H., Vanoverschelde J.L., Baudhuin T., Wijns W., Melin J.A., Detry J.R. How accurate is dobutamine stress electrocardiography for detection of coronary artery disease? Comparison with two-dimensional echocardiography and technetium-99m methoxyl isobutil isonitrile (Mibi) perfusion scintigraphy. J Am Coll Cardiol. 24:1994;920-927.
15. Segar D., Brown S.E., Sawada S.G., Ryan T., Feigenbaum H. Dobutamine stress echocardiography correlation with coronary lesion severity as determined by quantitative angiography . J Am Coll Cardiol. 19:1992;1197-2202.
16. Smart S.C., Sawada S., Ryan T., Segar D., Atherton L., Berkovitz K., Bourdillon P.D.V., Feigenbaum H. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation. 88:1993;405-415.
17. Bolognese L., Antoniucci D., Rovai D., Buonamici P.G., Cerisano G., Santoro G.M., Marini C., L'Abbate A., Fazzini P.F. Myocardial contrast echocardiography versus dobutamine echocardiography for predicting functional recovery after myocardial infarction treated with primary coronary angioplasty. J Am Coll Cardiol. 28:1996;1677-1683.
18. Meluzin J., Cerny J., Frelich M., Stetka F., Spinarova L., Popelova J., Stipal R. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol. 32:1998;912-920.
19. Hachamovitch R., Berman D.S., Kiat H., Cohen I., Cabico J.A., Friedman J., Diamond G.A. Exercise myocardial perfusion SPECT in patients without known coronary artery disease. Incremental prognostic value and use in risk stratification. Circulation. 93:1996;905-914.
20. Panza J.A., Dilsizian V., Laurienzo J.M., Curiel R.V., Katsiyiannis P.T. Relation between thallium uptake and contractile response to dobutamine. Implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation. 91:1995;990-998.
21. Baumgartner H., Porenta G., Lau Y.-K., Wutte M., Klaar U., Mehrabi M., Siegel R.J., Czernin J., Laufer G., Fishbein M.C., Maurer G. Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT. Correlation with histopathology in explanted hearts. J Am Coll Cardiol. 32:1998;1701-1708.
22. Bax J.J., Wijns W., Cornel J.H., Visser F.C., Boersma E., Fioretti P.M. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease comparison of pooled data . J Am Coll Cardiol. 30:1997;1451-1460.
23. Piwnica-Worms D., Kronauge J., Chiu M. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. Circulation. 82:1990;1826-1838.
24. Freeman I., Grunwald A.M., Hoory S., Bodenheimer M.M. Effect of coronary occlusion and myocardial viability on myocardial activity of technetium-99m-sestamibi. J Nucl Med. 32:1991;292-298.
25. Cornel J.H., Bax J.J., Elhendy A., Maat A.P., Kimman G.P., Geleijnse M.L., Rambaldi R., Boersma E., Fioretti P.M. Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease. Implications of time course of recovery on diagnostic accuracy. J Am Coll Cardiol. 31:1998;1002-1010.
26. Afridi I., Grayburn P.A., Panza J.A., Oh J.K., Zoghbi W.A., Marwick T.H. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol. 32:1998;921-926.
27. Afridi I., Kleiman N.S., Raizner A.E., Zoghbi W.A. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation. 91:1995;663-670.